Cosmos Health Inc. (NASDAQ:COSM) shares are trading slightly lower on Friday. The company revealed that its wholly owned ...

Fanuc robots 'ease pain' for Takeda Pharmaceutical February 7, 2025 by Mark Allinson A collaborative robotic solution from Fanuc ...

Pharmaceutical packaging market growth is propelled by its critical role in dosing, dispensing, and administering pharmaceutical products.New Delhi, Feb. 07, 2025 (GLOBE NEWSWIRE) -- The global ...

Hyderabad: NATCO Pharma Limited has announced final approval of its Abbreviated New Drug Application (ANDA) for Bosentan ...

Panaji: The Goa Investment Promotion Board on Wednesday gave an in-principle approval for nine projects, which have the ...

Natco Pharma said that it has received final approval of its ANDA for Bosentan tablets for oral suspension (TFOS), which is a generic version of Tracleer by Actelion Pharmaceuticals US Inc.

Cosmos Health (COSM) announced that its wholly owned subsidiary, Cana Laboratories, has entered into a new long-term ten-year contract ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...

Ass.-Prof. Priv.-Doz. Dr Doris E. Braun Head of the Christian Doppler Laboratory Followed by drinks in front of the auditorium.

CHICAGO - Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group with a market capitalization of $15.18 million, has announced a new 10-year contract manufacturing agreement through its ...